Prestige Consumer Healthcare Inc. (NYSE:PBH – Get Rating)'s share price hit a new 52-week low during trading on Thursday . The company traded as low as $49.81 and last traded at $49.81, with a volume of 18 shares. The stock had previously closed at $50.55.
Analysts Set New Price Targets
Separately, DA Davidson reaffirmed a "neutral" rating on shares of Prestige Consumer Healthcare in a report on Tuesday, August 9th. Two equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company's stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $80.50.
Get Prestige Consumer Healthcare alerts:Prestige Consumer Healthcare Price Performance
The company has a current ratio of 2.09, a quick ratio of 1.23 and a debt-to-equity ratio of 0.93. The firm has a market cap of $2.50 billion, a PE ratio of 12.67, a price-to-earnings-growth ratio of 1.51 and a beta of 0.55. The stock has a 50 day simple moving average of $55.44 and a 200-day simple moving average of $55.50.
Institutional Investors Weigh In On Prestige Consumer Healthcare
A number of institutional investors have recently bought and sold shares of the business. BlackRock Inc. increased its stake in Prestige Consumer Healthcare by 12.4% in the 1st quarter. BlackRock Inc. now owns 9,115,718 shares of the company's stock worth $482,584,000 after buying an additional 1,004,337 shares in the last quarter. Vanguard Group Inc. increased its stake in Prestige Consumer Healthcare by 1.1% in the 1st quarter. Vanguard Group Inc. now owns 5,559,553 shares of the company's stock worth $294,322,000 after buying an additional 59,740 shares in the last quarter. Dimensional Fund Advisors LP grew its position in shares of Prestige Consumer Healthcare by 0.4% during the first quarter. Dimensional Fund Advisors LP now owns 3,448,246 shares of the company's stock valued at $182,552,000 after purchasing an additional 12,790 shares in the last quarter. State Street Corp grew its position in shares of Prestige Consumer Healthcare by 4.9% during the second quarter. State Street Corp now owns 1,921,456 shares of the company's stock valued at $112,982,000 after purchasing an additional 89,131 shares in the last quarter. Finally, Macquarie Group Ltd. grew its position in shares of Prestige Consumer Healthcare by 4.4% during the second quarter. Macquarie Group Ltd. now owns 1,887,479 shares of the company's stock valued at $110,984,000 after purchasing an additional 79,519 shares in the last quarter. Hedge funds and other institutional investors own 99.37% of the company's stock.About Prestige Consumer Healthcare
(Get Rating)
Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.
Featured Stories
- Get a free copy of the StockNews.com research report on Prestige Consumer Healthcare (PBH)
- The Institutions Hold On To Darden Restaurants International
- What Steelcase's Earnings Say About the Return to the Office?
- Is The Golden Age Of Homebuilding Already Over?
- These 3 Big Dividend Payers Also Boast Strong Price Growth
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.